NKMAX Co., Ltd.
Develops NK cell-based therapies, diagnostics, and biological products.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7182400002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
Description
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-10 00:00 |
기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)
|
Korean | 3.3 KB | ||
| 2025-03-31 00:00 |
[기재정정]사업보고서 (2024.12)
|
Korean | 1.7 MB | ||
| 2025-03-24 00:00 |
사업보고서 (2024.12)
|
Korean | 492.6 KB | ||
| 2025-03-21 00:00 |
감사보고서제출
|
Korean | 27.2 KB | ||
| 2025-03-21 00:00 |
주권매매거래정지기간변경 (상장폐지 사유 발생)
|
Korean | 5.4 KB | ||
| 2025-03-21 00:00 |
기타시장안내 (상장폐지 관련)
|
Korean | 3.8 KB | ||
| 2025-03-13 00:00 |
[기재정정]기타경영사항(자율공시) (관계인집회 기일 결정)
|
Korean | 11.6 KB | ||
| 2025-02-28 00:00 |
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
|
Korean | 23.2 KB | ||
| 2025-02-28 00:00 |
기타시장안내 (상장폐지 사유 추가 우려 및 관리종목 지정사유 추가 우려 안내)
|
Korean | 5.0 KB | ||
| 2025-02-05 00:00 |
기타경영사항(자율공시) (관계인집회 기일 결정)
|
Korean | 7.8 KB | ||
| 2024-12-31 00:00 |
투자판단관련주요경영사항 (M&A최종인수예정자 선정허가결정)
|
Korean | 10.0 KB | ||
| 2024-12-18 00:00 |
[기재정정]회생절차개시결정
|
Korean | 11.1 KB | ||
| 2024-11-27 00:00 |
기타경영사항(자율공시) (회생회사 주식회사 엔케이맥스 M&A 공고)
|
Korean | 10.4 KB | ||
| 2024-11-26 00:00 |
기타경영사항(자율공시) (M&A 조건부 투자계약 체결)
|
Korean | 4.9 KB | ||
| 2024-11-21 00:00 |
[기재정정]회생절차개시결정
|
Korean | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NKMAX Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
